CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
批准号:
3857836
负责人:
ROY CURTISS
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ultimate goal is to construct one or more safe, efficacious,
recombinant avirulent Salmonella vaccine strains, each expressing one or
more sperm- or egg-specific antigens that would, upon oral immunization,
induce immune responses to inhibit and/or prevent the fertilization
process. In general, species of Salmonella will be attenuated by
introduction of delta/cya/delta/crp mutations, and further modified to
decrease survivability in blood, to be excreted in a totally avirulent
nonimmunogenic form with reduced survival in nature and minimal probability
for causing immunization of those not elected to be immunized. Genetic
information for expression of sperm-specific and egg-specific antigens will
be contained on multi-copy plasmid vectors of the balanced lethal type,
wherein the asd+ gene on the vector complements a delta/asd chromosomal
mutation imposing a requirement for diaminopimelic acid (DAP). Genetic
information defining important sperm-specific and egg-specific antigens
will be based on studies being conducted by other Center members as well as
by other scientists conducting related research. The vectors with DNA
inserts will be designed and constructed to enhance transcription and
translation and to reduce breakdown of the protein product. We will also
employ the best available methods to enhance and/or restrict the type of
immune response by inclusion of sequences encoding adjuvants, immune
enhancers and/or modulators and specific epitopes to enhance SIgA mucosal
or IgG humoral or various cellular immune responses. The various
constructs will be evaluated in a diversity of in vitro tests and the S.
typhimurium and S. choleraesuis derivatives for stability and
immunogenicity in mice and rabbits. Suitable S. typhi and S. paratyphi A
constructs will also be made for use with primates and ultimately humans.
The research will make use of modern technologies in the fields of
microbiology, immunology, genetics, molecular biology and animal sciences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
-
批准号:5212802
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROY CURTISS
-
依托单位:--
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
-
批准号:3779295
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROY CURTISS
-
依托单位:
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
-
批准号:3843084
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROY CURTISS
-
依托单位:
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
-
批准号:3735617
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROY CURTISS
-
依托单位:
CORE--ORAL RECOMBINANT SALMONELLA ANTIFERTILITY VACCINES CORE
-
批准号:3757366
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROY CURTISS
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: